WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 18'5301 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 26'3551 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 1'313  1'316  1'320  1'324  1'328  1'399  1'565  1'474 
Births 14  14  14  15  15  13  21  22 
Surviving infants 14  14  14  14  15  13  20  22 
Pop. less than 5 years 72  73  75  78  79  61  119  109 
Pop. less than 15 years 211  208  206  204  203  246  347  319 
Female 15-49 years 288  294  299  305  311  348  380  372 

Number of reported cases

(Click for retrospective incidence data for Estonia)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  33 
Mumps
ChartChart
  10  12  63 
Pertussis
ChartChart
  77  43  55  149  478  503  87 
Polio*
ChartChart
 
Rubella
ChartChart
  370 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Estonia)
Vaccine year result method % card seen                                                
BCG          95  95  96  97  99  99* 
DTP1          94  95  96  96  96  96 
DTP3          93  93  94  94  93  93 
DTP4          92  92 
IPV1          95  95 
HepB_BD          16 
HepB3          91  93  93  94  94 
Hib3          93  93  94  94  93 
JapEnc         
MCV1          93  93  94  94  94  93 
MCV2          92  93  92  94  95  89 
PCV1         
PCV3         
Pol3          93  93  94  94  93  93 
Rota1          67  61 
RotaC          66  35 
Rubella1          93  93  94  94  94 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Estonia)
BCG
ChartChart
  95  95  96  97  99  99 
DTP1
ChartChart
  94  95  96  96  96  96 
DTP3
ChartChart
  93  93  94  94  93  93 
HepB3
ChartChart
  91  93  93  94  94 
HepB_BD
ChartChart
 
Hib3
ChartChart
  93  93  94  94  93 
MCV1
ChartChart
  93  93  94  94  94  93 
MCV2
ChartChart
  92  93  92  94  95  89 
PCV3
ChartChart
 
Pol3
ChartChart
  93  93  94  94  93  93 
RCV1
ChartChart
  93  93  94  94  94  93 
RotaC
ChartChart
  64  32 

Number of districts in the country 15  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 93
From 80 to 89% 7
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1-5 days; Yes
DT 3, 4.5, 6 months; 2, 6-7 years; Yes children with contraindication to pertussis component
DTaPHibIPV 3, 4.5, 6 months; 2 years; Yes
DTaPIPV 6-7 years; Yes
HepB_Pediatric birth; 1, 6 months; Yes or 12 years; +1, +6 months;
Hib 3, 4.5, 6 months; 2 years; Yes children with contraindication to pertussis component
IPV 3, 4.5, 6 months; 2, 6-7 years; Yes children with contraindication to pertussis component or above Y14 if incomplete vaccination
Influenza_Adult >= 65 years; and pregnant women, adults with chronic diseases, health care workers, Haj and travelers and other risk groups
Influenza_Pediatric > 6 months; Yes and children with chronic disease
MMR 1, 13 years; Yes
Rabies Yes pre and post-exposure prevention
Rotavirus 2, 3, 4.5 months; Yes
Td 25 years; Yes every 10 years; children with contrindication to pertussis component and children > 14 years with uncomplete vaccination schedule and post-trauma vaccination
Tdap 15-16 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2016  2015-2016  2013-2014  2013-2014  2011-2013  2011-2013  2010-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 15  15  15  15  15  16  15 

System performance

Total Nº districts in country number 15  15  15  15  15  16  16 
Nº districts with DTP3 coverage >=80% number 15  15  15  15  15     
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100     
Nº districts with measles (MCV1) coverage >=95% number 11  10  11     
% of districts with MCV1 coverage >=95% From 0 to 100% 40  60  73  67  73     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100    100  100  100    100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.